C6orf204 anticorps (AA 451-550) (Cy5)
-
- Antigène Voir toutes C6orf204 (CEP85L) Anticorps
- C6orf204 (CEP85L) (Centrosomal Protein 85kDa-Like (CEP85L))
-
Épitope
- AA 451-550
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp C6orf204 est conjugé à/à la Cy5
-
Application
- Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Homologie
- Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human C6orf204
- Isotype
- IgG
- Top Product
- Discover our top product CEP85L Anticorps primaire
-
-
- Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- C6orf204 (CEP85L) (Centrosomal Protein 85kDa-Like (CEP85L))
- Autre désignation
- C6orf204 (CEP85L Produits)
- Synonymes
- anticorps C6orf204, anticorps NY-BR-15, anticorps bA57K17.2, anticorps centrosomal protein 85 like, anticorps CEP85L
- Sujet
-
Synonyms: bA57K17.2, C6orf204, centrosomal protein 85 kDa-like, CE85L_HUMAN, Coiled-coil domain-containing protein C6orf204, NY-BR-15, RP11-57K17.2, Serologically defined breast cancer antigen NY-BR-15.
Background: Making up nearly 6 % of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf204 gene product has been provisionally designated C6orf204 pending further characterization.
- ID gène
- 387119
-